e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Management of COPD and other respiratory diseases in primary care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The sensitivity and positive predictive value of GP two-week wait referrals for lung cancer
Mihir Sanghvi (Watford, United Kingdom), Mihir Sanghvi, Ali Mohammed
Source:
International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Session:
Management of COPD and other respiratory diseases in primary care
Session type:
Thematic Poster Session
Number:
3865
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Mihir Sanghvi (Watford, United Kingdom), Mihir Sanghvi, Ali Mohammed. The sensitivity and positive predictive value of GP two-week wait referrals for lung cancer. Eur Respir J 2015; 46: Suppl. 59, 3865
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Reducing the rate of emergency presentation in lung cancer
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
A temporal increase in referrals to a two-week wait lung cancer clinic is not explained by an increase in inappropriate referrals
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016
Do doctors understand the test characteristics of lung cancer screening? – A randomized trial
Source: International Congress 2016 – A view into a chest and pleural pathology
Year: 2016
Assessing the local impact of a national lung cancer awareness campaign
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013
Number of procedures and time needed to diagnose lung cancer: Being right the first time
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Feasibility of lung cancer screening in a population of patients with emphysema and/or COPD meeting NLST criteria
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Improving survival for NSCLC patients in the national lung cancer audit
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Hospitalization costs of lung cancer diagnosis in Turkey: Is there a difference between histological types and stages?
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015
Lung cancer in England: Trends in survival over the duration of the national lung cancer audit
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013
The influence of the UK national lung cancer campaign on fast-track referrals to secondary care
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013
Patient and doctor delays in the diagnosis and treatment of non-small cell lung cancer in Turkey
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013
A feasibility study: Home-telemonitoring for rural lung cancer patients
Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education
Year: 2013
Assessment of nutritional status in patients with primary lung cancer
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Population’s understanding and degree of participation of a screening lung cancer programme
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Improving NLST criteria for lung cancer screening
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Defining a standard set of patient-centered outcomes for patients with lung cancer
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Assessment of pain and nutritional status in patients suffering from lung cancer
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016
Eligibility for lung cancer screening in Australia and the effect on screening eligibility of using spirometry to identify COPD
Source: International Congress 2016 – Highlights in the management of COPD and beyond
Year: 2016
Symptom occurrence in lung cancer patients prior to surgery
Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education
Year: 2013
The two week wait pathway: Is it used appropriately?
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept